Healthcare sector | Medical Devices industry
| Price | $6.74 |
|---|---|
| Shares Outstanding | 1.52M |
| All-Time Low | $4.14 |
| 52-Week Low | $4.14 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $4.55 |
| Net Tangible Assets / Share | $5.25 |
| Max Earning Power / Share | $-19.1 |
|---|---|
| Adjusted Earning Power |
$-19.8
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((-3,170,000 / 0.105) / 1,524,481) = -19.8038 |
| Non-Cash Charges to Market Cap |
0.81%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-20-2026 |
| Consecutive Years Paid | No | 3-20-2026 |
| Pays Dividend | No | 3-20-2026 |
| Last Dividend Date | 3-31-19 | |
| Income indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-20-2026 |
| EBITDA Positive | No | 3-20-2026 |
| Net Income Positive | No | 3-20-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 1 quarterly.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-09-30 | Quarterly | $5.69 | 8M ($8,000,000) | 1.4M (1,405,238) |
Revenue from income statements.
| Report Date | Revenue |
|---|---|
| No annual revenue history available yet | |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| No recent share changes | ||
Latest short-interest change: 228,488 shares (15.17% of float) | Days to cover: 11.24
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 228,488 shares | +32,494 | +16.58% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.